Trial Profile
Effect of Sitagliptin on Glycemic Control, Post-prandial Glucagon, and Inflammation in Type 1 Diabetics
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 28 Mar 2022
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 08 Mar 2022 Status changed from discontinued to withdrawn prior to enrolment.
- 14 Jan 2022 Status changed from recruiting to discontinued.
- 09 Jan 2013 New trial record